Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1987-7-8
pubmed:abstractText
The metabolism of 17 alpha-ethinyloestradiol (EE2) to catechol and reactive metabolites by human liver microsomes was investigated. 2-Hydroxyethinyloestradiol (2-OHEE2) was either the sole or principal metabolite. Small amounts of 6-hydroxyethinyloestradiol and 16-hydroxyethinyloestradiol were produced by some of the livers. EE2 (10 microM) underwent substantial (5-20% of incubated drug), though highly variable, NADPH-dependent metabolism to material irreversibly bound to microsomal protein. 2-OHEE2 appeared to be the pro-reactive metabolite. The maximum EE2 2-hydroxylase activity was 0.67 nmol min-1 mg-1 microsomal protein, with a Km value of 8.6 microM. Oestradiol, which is mainly hydroxylated to 2-hydroxyoestradiol, was the most potent inhibitor of hydroxylase activity and exhibited competitive inhibition. Progesterone, which undergoes 2-hydroxylation to a minor extent was also a competitive inhibitor, whereas cholesterol and cortisol did not have any appreciable inhibitory effect. Primaquine was the most potent non-steroidal inhibitor but was non-competitive. Other non-steroidal compounds investigated, e.g. antipyrine, did not show any significant effect on EE2 2-hydroxylation. The results of this study suggest that EE2 2-hydroxylation is metabolised by a form(s) of cytochrome P-450 which has affinity for endogenous steroids.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-1164851, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-1274368, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-14209971, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-164063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-2867882, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-3002362, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-3079764, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-3514607, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-3724146, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-3970543, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-4027115, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-4210249, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-4214831, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-4215423, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-5440628, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6144489, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6279963, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6372265, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6383273, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6477128, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6487376, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6487500, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6621036, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6627809, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6659545, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-6682170, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-7050382, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-7157835, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-7168193, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-7297566, http://linkedlifedata.com/resource/pubmed/commentcorrection/3555579-942437
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0306-5251
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
447-53
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.
pubmed:publicationType
Journal Article, In Vitro